Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patients

Administration of anti–PD-1 is now a standard therapy in advanced non-small cell lung carcinoma (NSCLC) patients. The clinical application of biomarkers reflecting tumor immune microenvironment is hurdled by the invasiveness of obtaining tissues despite its importance in immunotherapy. This study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Qianqian, Xiong, Fu, Zhu, Peng, Chang, Xiaona, Wang, Guobin, He, Nan, Jin, Qianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390967/
https://www.ncbi.nlm.nih.gov/pubmed/35992867
http://dx.doi.org/10.3389/fonc.2022.952749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390967/
https://www.ncbi.nlm.nih.gov/pubmed/35992867
http://dx.doi.org/10.3389/fonc.2022.952749

Ejemplares similares